Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2028

Conditions

Leber's Hereditary Optic Neuropathy (LHON)

Interventions

DRUG

NR082 injection

Intravitreal injection（IVT）

DEVICE

Sham Injection

Sham Intravitreal Injection

Trial Locations (1)

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Wuhan Neurophth Biotechnology Limited Company

OTHER